Dealing with the legacy of previous cancer treatment
MediSurg Global Learning Portal. Piso P. 11/09/12; 25404
Disclosure(s): sources of the slides have been shown on other occasions
Pompiliu Piso
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Learning Objectives
Rate & Comment (0)
After viewing this presentation, the participant will be able to:
Describe candidates for a multimodal treatment of peritoneal carcinomatosis
Mention rationale and drugs for Hyperthermic Interperitoneal Chemotherapy (HIPEC)
Describe candidates for a multimodal treatment of peritoneal carcinomatosis
Mention rationale and drugs for Hyperthermic Interperitoneal Chemotherapy (HIPEC)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}